Sankyo signs up Singapore pharma for natural product leads

By Renate Krelle
Thursday, 21 April, 2005

Private Singapore natural products company MerLion Pharmaceuticals has sealed a three-year cooperative drug discovery and development collaboration with Japan's Sankyo.

The companies will collaborate on both the lead discovery and optimisation stages of the collaboration. Sankyo will provide selected high-throughput screens and additional assays to MerLion, which will provide access to its sample collection. Sankyo will undertake clinical development and commercialisation of the discoveries.

Related News

Mouth bacteria linked to increased head and neck cancer risk

More than a dozen bacterial species that live in people's mouths have been linked to a...

Life expectancy gains are slowing, study finds

Life expectancy at birth in the world's longest-living populations has increased by an...

Towards safer epilepsy treatment for pregnant women

New research conducted in organoids is expected to provide pregnant women with epilepsy safer...


  • All content Copyright © 2024 Westwick-Farrow Pty Ltd